Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
About 30% of persons with epilepsy have seizures that do not respond to drugs. The ketogenic
diet is an effective treatment option for them, but this high fat diet is strict and
difficult to maintain. The properties of gliflozins, which often are used to treat type 2
diabetes, make them a potential replacement for the ketogenic diet. This pilot study will
determine whether gliflozins induce ketosis and could be used to treat adults with epilepsy
safely.